Publication:
Incidence of Lymphoproliferative Disorders After Renal Transplantation is Down, but the Poor Prognosis Remains. Multicenter 32-Year Cohort Study.

No Thumbnail Available

Date

2022-11-12

Authors

Franco, Antonio
Hernández, Domingo
Más-Serrano, Patricio
Zarraga, Sofia
Sanchez, Ana
Crespo, Marta
Mazuecos, Auxiliadora
Diaz-Corte, Carmen
Rodriguez-Benot, Alberto
Jimenez, Carlos

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Post-transplant lymphoproliferative disorders represent rare but serious complications of kidney transplantation. We assessed incidence, risk factors, and outcomes in 21,546 patients receiving grafts between 1990 and 2009. Data were compared by decade of transplant (1990-1999 vs 2000-2009). Patients were followed for at least 12 years over a 32-year study period. In total, 331 patients (1.5%) developed PTLD: 189 of 9740 transplanted in the first decade, and 142 of 11,806 in the second. Incidence decreased significantly (19.40 vs12.02 cases/1000 patients; P Post-transplant lymphoproliferative disorders have a low and decreasing incidence, but the poor prognosis has not changed.

Description

MeSH Terms

Humans
Kidney Transplantation
Epstein-Barr Virus Infections
Incidence
Herpesvirus 4, Human
Cohort Studies
Postoperative Complications
Lymphoproliferative Disorders
Risk Factors
Prognosis
Retrospective Studies

DeCS Terms

CIE Terms

Keywords

Citation